Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Apr;67(7):1025-48.
doi: 10.1007/s00018-009-0213-1. Epub 2009 Nov 25.

CAS proteins in normal and pathological cell growth control

Affiliations
Review

CAS proteins in normal and pathological cell growth control

Nadezhda Tikhmyanova et al. Cell Mol Life Sci. 2010 Apr.

Abstract

Proteins of the CAS (Crk-associated substrate) family (BCAR1/p130Cas, NEDD9/HEF1/Cas-L, EFS/SIN and CASS4/HEPL) are integral players in normal and pathological cell biology. CAS proteins act as scaffolds to regulate protein complexes controlling migration and chemotaxis, apoptosis, cell cycle, and differentiation, and have more recently been linked to a role in progenitor cell function. Reflecting these complex functions, over-expression of CAS proteins has now been strongly linked to poor prognosis and increased metastasis in cancer, as well as resistance to first-line chemotherapeutics in multiple tumor types including breast and lung cancers, glioblastoma, and melanoma. Further, CAS proteins have also been linked to additional pathological conditions including inflammatory disorders, Alzheimer's and Parkinson's disease, as well as developmental defects. This review will explore the roles of the CAS proteins in normal and pathological states in the context of the many mechanistic insights into CAS protein function that have emerged in the past decade.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
CAS protein structure and interactions. a CAS proteins conserve a common structure marked by four discrete domains: SH3 domain, an unstructured substrate domain, a 4-helix bundle, and an evolutionarily conserved C-terminal domain. Crystal structures have been obtained for the SH3 domain (1wyx) of human BCAR1 and 4-helix bundle (1z23) of rat BCAR1 are shown. Secondary structure predictions for the C-terminal domain are also shown; pattern of α-helices has some features of a focal adhesion-targeting (FAT) domain, but is not exactly the same. Amino acid sequences correspond to those for human BCAR1, and vary slightly for other family members. b For a number of important CAS interacting proteins, exact domains of interaction have been mapped, and are shown. Proteins known to interact with the substrate domain specifically through SH2/phospho-tyrosine interactions are thus indicated. A poly-proline domain common to BCAR1 and EFS is shown (Pro). See text for details
Fig. 2
Fig. 2
Upstream regulators of CAS mRNA and protein expression, and protein activation. Signaling proteins inducing transcription of CAS proteins, or influencing their phosphorylation or dephosphorylation, are indicated. In addition, some stimuli such as hypoxia induce dynamic changes in CAS expression or modification, but specific proteins mediating the responses are unknown. See text for details
Fig. 3
Fig. 3
CAS proteins in cell migration. Activation or overexpression of CAS proteins activates multiple downstream effectors to promote formation of filopodia, lamellipodia, pseudopodia, invadopodia, and induce additional changes in the cytoskeleton that support migration. See text for details
Fig. 4
Fig. 4
CAS proteins in apoptosis. Pro-apoptotic stimuli trigger dephosphorylation and cleavage of CAS proteins, leading to direct dominant-negative mediated focal adhesion disassembly, altering the transcriptional balance between CAS-dependent pro- and anti-survival factors. Overexpression of NEDD9 can induce cell cycle checkpoints that trigger apoptosis through additional routes. See text for details

Similar articles

Cited by

References

    1. Kanner SB, Reynolds AB, Parsons JT. Tyrosine phosphorylation of a 120-kilodalton pp60src substrate upon epidermal growth factor and platelet-derived growth factor receptor stimulation and in polyomavirus middle-T-antigen-transformed cells. Mol Cell Biol. 1991;11:713–720. - PMC - PubMed
    1. Reynolds AB, Roesel DJ, Kanner SB, Parsons JT. Transformation-specific tyrosine phosphorylation of a novel cellular protein in chicken cells expressing oncogenic variants of the avian cellular src gene. Mol Cell Biol. 1989;9:629–638. - PMC - PubMed
    1. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, Mano H, Yazaki Y, Hirai H. A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J. 1994;13:3748–3756. - PMC - PubMed
    1. Brinkman A, van der Flier S, Kok EM, Dorssers LC. BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells. J Natl Cancer Inst. 2000;92:112–120. - PubMed
    1. Ishino M, Ohba T, Sasaki H, Sasaki T. Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene. 1995;11:2331–2338. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources